Compare IMA & NOMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMA | NOMA |
|---|---|---|
| Founded | 2019 | 2023 |
| Country | United States | United States |
| Employees | 17 | 8 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 65.4M |
| IPO Year | N/A | N/A |
| Metric | IMA | NOMA |
|---|---|---|
| Price | $5.84 | $3.25 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 42.8K | 8.1K |
| Earning Date | 05-15-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.94 | $2.55 |
| 52 Week High | $17.50 | $10.00 |
| Indicator | IMA | NOMA |
|---|---|---|
| Relative Strength Index (RSI) | 55.70 | 47.45 |
| Support Level | $5.23 | $3.35 |
| Resistance Level | $6.21 | $4.69 |
| Average True Range (ATR) | 0.37 | 0.45 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 91.40 | 68.70 |
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Nomadar Corp operates at the intersection of sports and technology, focusing on high-performance training programs and cultural exchange. The company aims to connect athletes, coaches, and fans through inventive technological solutions, enhancing sports development beyond physical borders. It offers services like the High Performance Training (HPT) program and promotes the legacy of iconic athletes. The Company generates revenue through its High Performance Training Program and events management at the JP Financial Stadium.